ID: ALA3577179

Max Phase: Preclinical

Molecular Formula: C26H44NO9P

Molecular Weight: 545.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCOc1ccccc1CCC(=O)OCCCOP(=O)(O)OC[C@H](N)C(=O)O

Standard InChI:  InChI=1S/C26H44NO9P/c1-2-3-4-5-6-7-8-9-12-18-33-24-15-11-10-14-22(24)16-17-25(28)34-19-13-20-35-37(31,32)36-21-23(27)26(29)30/h10-11,14-15,23H,2-9,12-13,16-21,27H2,1H3,(H,29,30)(H,31,32)/t23-/m0/s1

Standard InChI Key:  YBPJQSQZGMFTDC-QHCPKHFHSA-N

Associated Targets(Human)

Probable G-protein coupled receptor 34 197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Putative P2Y purinoceptor 10 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Probable G-protein coupled receptor 174 370 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Putative P2Y purinoceptor 10 276 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

G protein-coupled receptor 34 411 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 545.61Molecular Weight (Monoisotopic): 545.2754AlogP: 5.01#Rotatable Bonds: 23
Polar Surface Area: 154.61Molecular Species: ZWITTERIONHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.58CX Basic pKa: 9.38CX LogP: 3.44CX LogD: 0.36
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.10Np Likeness Score: 0.38

References

1. Ikubo M, Inoue A, Nakamura S, Jung S, Sayama M, Otani Y, Uwamizu A, Suzuki K, Kishi T, Shuto A, Ishiguro J, Okudaira M, Kano K, Makide K, Aoki J, Ohwada T..  (2015)  Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174.,  58  (10): [PMID:25970039] [10.1021/jm5020082]
2. Sayama M, Inoue A, Nakamura S, Jung S, Ikubo M, Otani Y, Uwamizu A, Kishi T, Makide K, Aoki J, Hirokawa T, Ohwada T..  (2017)  Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS1 by Docking-Aided Structure-Activity Analysis.,  60  (14): [PMID:28715213] [10.1021/acs.jmedchem.7b00693]

Source